AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25792492
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg once weekly
Trial: 12769445
Drug: Oat bran
RxNorm normalized name: Oat bran
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oat bran intervention (60 g oat bran daily, corresponding to 20 g dietary fiber)
Trial: 7831429
Drug: Yohimbine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (0.4 mg/kg)
Trial: 3928015
Drug: 0.15 mg
RxNorm normalized name: iodine 0.15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg vitamin K1 per week
Trial: 3928015
Drug: 20.15 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20.15 mg vitamin K1 per week
Trial: 3928015
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg vitamin K1 per day
Trial: 19185249
Drug: Capsules of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules of nondiabetic patients without trypan blue
Trial: 19185249
Drug: Capsules of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsules of diabetic patients without trypan blue
Trial: 15185837
Drug: Guided self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-help treatment (GSH)
Trial: 15185837
Drug: Minimal guided
RxNorm normalized name: Centipeda minima whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal guided self-help treatment (M-GSH)
Trial: 1551787
Drug: Fluoxetine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (8 weeks treatment)
Trial: 25149384
Drug: Placebo (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (8 weeks treatment)
Trial: 3925744
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN), 40 to 120 mg/day
Trial: 3925744
Drug: Nifedipine, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine, 40 to 120 mg/day
Trial: 3925744
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of ISDN and calcium antagonist
Trial: 20582970
Drug: LSA2L2-type maintenance
RxNorm normalized name: cenobamate
DrugBank: Cenobamate (DB06119)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: LSA2L2-type maintenance therapy
Trial: 14585938
Drug: Ximelagatran 36
RxNorm normalized name: Ximelagatrán
DrugBank: Ximelagatran (DB04898)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ximelagatran 36 mg twice daily
Trial: 1312854
Drug: Lisinopril (10-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (10-40 mg twice daily)
Trial: 2405556
Drug: Nifedipine (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20-40 mg twice daily)
Trial: 24494280
Drug: Acupuncture rehabilitation
RxNorm normalized name: GLUTATHIONE 12.5 g in 100 mL ORAL LIQUID [K2LTS Brain Rehabilitation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture rehabilitation group (acupuncture at specific points plus comprehensive rehabilitation therapy)
Trial: 24494280
Drug: Simple rehabilitation
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple rehabilitation group (comprehensive rehabilitation therapy only)
Trial: 21563716
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group interventions (visual assessment, education, bed/pillow dust mite encasings, treatment of lead‐based paint hazards)
Trial: 8521433
Drug: 1-min active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-min active mouthrinse with toothpaste-foam combined with 10 ml of water after brushing for 2 min
Trial: 8521433
Drug: 3 thorough
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3 thorough rinsings of approximately 15 ml water each after brushing for 2 min
Trial: 2089286
Drug: Continuous therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous therapy with 400 mg/day of cimetidine for 1 year
Trial: 2089286
Drug: Seasonal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seasonal therapy with 400 mg/day of cimetidine for 4 months a year
Trial: 27852613
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g vitamin C-enriched gelatin
Trial: 27852613
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g vitamin C-enriched gelatin
Trial: 25060839
Drug: Intranasal buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal buprenorphine (8 mg)
Trial: 25060839
Drug: Intranasal buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal buprenorphine (16 mg)
Trial: 25060839
Drug: Buprenorphine/naloxone (8/2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine/naloxone (8/2, 8/8, 8/16, 16/4 mg)
Trial: 7407606
Drug: Naloxone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (4 mg)
Trial: 25060839
Drug: Heroin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heroin (100 mg)
Trial: 21720299
Drug: sinuforte (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sinuforte (one dose administered daily into each half of the nasal cavity)
Trial: 19854960
Drug: Sonographically guided
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonographically guided injections of hyaluronic acid (HA)
Trial: 19854960
Drug: Blind injections
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind injections of hyaluronic acid (HA)
Trial: 16412748
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg of letrozole
Trial: 16412748
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of letrozole
Trial: 15260909
Drug: Venlafaxine 37.5
RxNorm normalized name: venlafaxine 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 37.5 mg b.i.d.
Trial: 15260909
Drug: Dothiepin 25
RxNorm normalized name: dothiepin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dothiepin 25 mg mane followed by 50 mg nocte
Trial: 8095383
Drug: Atracurium (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium (0.4 mg.kg‐1 BW)
Trial: 8095383
Drug: Vecuronium (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (0.08 mg.kg‐1 BW)
Trial: 27475844
Drug: Thrombectomy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombectomy and intracoronary administration of tirofiban (Group A)
Trial: 24930201
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus a 12-week post-exacerbation pulmonary rehabilitation (PEPR) programme
Trial: 24930201
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment without pulmonary rehabilitation (CTWPR)
Trial: 20127562
Drug: Low-dose lomitapide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose lomitapide (AEGR-733)
Trial: 20127562
Drug: High-dose MTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose MTP inhibitors (not specified)
Trial: 14977161
Drug: Nasal spray
RxNorm normalized name: Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal spray
Trial: 29423865
Drug: High-volume corticosteroid
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-volume corticosteroid injections (HCI) - 10 mL total volume of 1% lidocaine plus 40 mg TA
Trial: 29423865
Drug: Low-volume corticosteroid
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-volume corticosteroid injections (LCI) - 4 mL total volume of 1% lidocaine plus 40 mg TA
Trial: 22245891
Drug: Vandetanib (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vandetanib (both doses)
Trial: 10227009
Drug: 1.25 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg/day Tibolone
Trial: 10227009
Drug: 2.5 mg/day
RxNorm normalized name: Androderm 2.5 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/day Tibolone
Trial: 8880942
Drug: d-amphetamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (10 mg BID)
Trial: 8880942
Drug: placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo (0 mg BID)
Trial: 6394505
Drug: Intravenous penicillin
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous penicillin therapy
Trial: 6394505
Drug: Oral penicillin
RxNorm normalized name: penicillin G Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral penicillin therapy
Trial: 31479120
Drug: Intramyocardial injection
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAEPICARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramyocardial injection of mesenchymal precursor cells
Trial: 26861164
Drug: Placebo administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administration after four prior administrations of apomorphine
Trial: 26861164
Drug: Placebo administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administration after two, three, or four prior administrations of apomorphine
Trial: 26861164
Drug: Placebo administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administration for the first time
Trial: 20597828
Drug: Sensor-augmented insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sensor-augmented insulin pump therapy (SAP group)
Trial: 16266358
Drug: Topiramate (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (800 mg daily)
Trial: 14562135
Drug: Acupuncture specific
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture specific against erectile dysfunction (treatment group)
Trial: 14562135
Drug: Simultaneous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous treatment with 50 mg sildenafil
Trial: 29108526
Drug: Sleep Treatment
RxNorm normalized name: Sleep
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sleep Treatment at Acute Crisis (STAC) plus Standard Care (SC)
Trial: 27082758
Drug: Oral Instructions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Instructions to Third Person
Trial: 24126198
Drug: Adhesive patch
RxNorm normalized name: ADHESIVE PATCH, MEDICATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adhesive patch method
Trial: 17604143
Drug: Curcuminoids at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuminoids at 2000 mg/day for 7 weeks
Trial: 11114313
Drug: Fludarabine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine (25 mg/m² IV daily for 5 days every 28 days)
Trial: 11114313
Drug: Chlorambucil (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorambucil (40 mg/m² orally every 28 days)
Trial: 11114313
Drug: Fludarabine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine (25 mg/m²)
Trial: 11114313
Drug: Chlorambucil (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorambucil (40 mg/m²)
Trial: 8369211
Drug: Nickel sulphate
RxNorm normalized name: Nickel sulphate
DrugBank: Nickel sulfate (DB14180)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nickel sulphate patch tests with a 10-step nickel sulphate dilution series (TRUE test)
Trial: 8369211
Drug: Nickel sulphate
RxNorm normalized name: Nickel sulphate
DrugBank: Nickel sulfate (DB14180)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nickel sulphate patch tests with high concentrations
Trial: 3790957
Drug: 1 per
RxNorm normalized name: ALOE VESTA 2-N-1 PERINEAL CLEANSER SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 per cent topical povidone-iodine solution in addition to systemic antibiotics (gentamicin and metronidazole)
Trial: 3790957
Drug: Systemic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antibiotics (gentamicin and metronidazole) without topical agent
Trial: 27681601
Drug: Pre-operative DVD
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative DVD and standard preparation
Trial: 23990706
Drug: Etomidate emulsion
RxNorm normalized name: Etomidate
DrugBank: Etomidate (DB00292)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etomidate emulsion group 1 (E1) - 10 μg · kg(‐1) · min(‐1) combined with remifentanil (0.1 μg · kg(‐1) · min(‐1))
Trial: 23990706
Drug: Etomidate emulsion
RxNorm normalized name: Etomidate
DrugBank: Etomidate (DB00292)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etomidate emulsion group 2 (E2) - 15 μg · kg(‐1) · min(‐1) combined with remifentanil (0.2 μg · kg(‐1) · min(‐1))
Trial: 23990706
Drug: Etomidate emulsion
RxNorm normalized name: Etomidate
DrugBank: Etomidate (DB00292)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etomidate emulsion group 3 (E3) - 20 μg · kg(‐1) · min(‐1) combined with remifentanil (0.2 μg · kg(‐1) · min(‐1))
Trial: 23990706
Drug: Propofol group
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol group (P group) - 610 mg · kg(‐1) · h(‐1)
Trial: 16778652
Drug: PMMA implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMMA implant
Trial: 19248868
Drug: Multifamily therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multifamily therapy plus psychoeducation (n=15)
Trial: 16729277
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg ibandronate every 2 months
Trial: 16729277
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg ibandronate every 3 months
Trial: 16729277
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg oral ibandronate daily
Trial: 16729277
Drug: All intravenous
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All intravenous regimens
Trial: 12970329
Drug: Quinapril 40
RxNorm normalized name: quinapril 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 40 mg daily
Trial: 2656929
Drug: Intravenous ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ciprofloxacin therapy
Trial: 30314978
Drug: Empagliflozin 25
RxNorm normalized name: empagliflozin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin 25 mg/d
Trial: 25923485
Drug: Bilberry extract
RxNorm normalized name: Bilberry Extract
DrugBank: Bilberry (DB14235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilberry extract (BE) 480 mg/day
Trial: 23592479
Drug: Ghrelin administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ghrelin administration (300 min, supraphysiological dose)
Trial: 21762197
Drug: MTZ+AMX (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTZ+AMX (500 mg t.i.d.) for 14 days
Trial: 21762197
Drug: MTZ (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTZ (400 mg t.i.d.) for 14 days
Trial: 9249100
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) 2 mg x kg(‐1) x h(‐1)
Trial: 12831948
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 1.0 mg of Cu/2000 kcal and 99 mg of Mg/2000 kcal for 81 days
Trial: 12831948
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 1.0 mg of Cu/2000 kcal and 399 mg of Mg/2000 kcal for 81 days
Trial: 12831948
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 3.0 mg of Cu/2000 kcal and 99 mg of Mg/2000 kcal for 81 days
Trial: 12831948
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 3.0 mg of Cu/2000 kcal and 399 mg of Mg/2000 kcal for 81 days
Trial: 12831948
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of Mg/d
Trial: 9155573
Drug: Omeprazole (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (8 mg/hour after a bolus of 80 mg)
Trial: 9155573
Drug: Ranitidine (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (0.25 mg/kg/hour after a bolus of 50 mg)
Trial: 3297481
Drug: Kathon CG
RxNorm normalized name: CG-200745
DrugBank: CG-200745 (DB12259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kathon CG 15 ppm active ingredient in a leave-on body lotion
Trial: 3297481
Drug: Control lotion
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control lotion without Kathon CG
Trial: 31263013
Drug: Artificial tears
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tears gel (Vidisic Gel; Bausch and Lomb)
Trial: 27740878
Drug: AZD5423 (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5423 (selective glucocorticoid receptor modulator)
Trial: 20606083
Drug: Pazopanib (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pazopanib (800 mg once daily)
Trial: 23964934
Drug: Sunitinib (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib (50 mg once daily for 4 weeks, followed by 2 weeks without treatment)
Trial: 22024490
Drug: NUTRIOSE 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE 8 g/d
Trial: 22024490
Drug: NUTRIOSE 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE 14 g/d
Trial: 22024490
Drug: NUTRIOSE 18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE 18 g/d
Trial: 22024490
Drug: NUTRIOSE 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE 24 g/d
Trial: 18804132
Drug: IC51 vaccine
RxNorm normalized name: Japanese encephalitis vaccine IC51
DrugBank: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IC51 vaccine in TBE ELISA-positive subjects
Trial: 18804132
Drug: IC51 vaccine
RxNorm normalized name: Japanese encephalitis vaccine IC51
DrugBank: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IC51 vaccine in TBE ELISA-negative subjects
Trial: 14509504
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue (3 ml applied to the dissected mediastinum)
Trial: 10232311
Drug: Co-trimoxazole (trimethoprim
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (trimethoprim 160 mg, sulphamethoxazole 800 mg) daily
Trial: 6880226
Drug: Cimetidine 1
RxNorm normalized name: cimetidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1 g per day for 8 weeks followed by surgery if symptomatic recurrence occurs
Trial: 6880226
Drug: Repeated courses
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated courses of cimetidine 1 g per day for 8 weeks in case of recurrence
Trial: 6880226
Drug: Cimetidine treatment
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine treatment (single vs repeated courses)
Trial: 12959636
Drug: Aspirin 80
RxNorm normalized name: aspirin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 80 mg/day
Trial: 2876664
Drug: Aspirin 40
RxNorm normalized name: aspirin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 40 mg/day
Trial: 2876664
Drug: Aspirin 40
RxNorm normalized name: aspirin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 40 mg/day and 80 mg/day
Trial: 30054049
Drug: Single-agent cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Single-agent cetuximab (Arm-A)
Trial: 16921044
Drug: No systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No systemic therapy
Trial: 18504550
Drug: Tissue factor
RxNorm normalized name: Tissue factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tissue factor pathway inhibitor
Trial: 10770187
Drug: Alendronate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (5 mg) for 5 yr (group I)
Trial: 10770187
Drug: Alendronate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (20 mg) for 2 yr followed by 3 yr off therapy (group III)
Trial: 10770187
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for 3 yr followed by alendronate (5 mg) for 2 yr (group II)